Skip to content

Randomized, controlled intervention study to evaluate the PhysioFit app as mobile physical therapy for pain, quality of life, and physical function in rheumatic patients

Randomized, controlled intervention study to evaluate the PhysioFit app as mobile physical therapy for pain, quality of life, and physical function in rheumatic patients - Physio-Fit-Rheuma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00037731
Enrollment
120
Registered
2025-08-20
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M46

Interventions

Group 1: Intervention group: Patients receive the Physio-Fit app for 8 weeks. As part of the study, the app should be used 3 times a week for 15 minutes over 8 weeks, if possible. The practical applic

Sponsors

Uniklinik Erlangen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with inflammatory rheumatic diseases (e.g., rheumatoid arthritis, spondyloarthritis (psoriatic arthritis, axial spondyloarthritis), myositis, scleroderma, vasculitis), patients at increased risk of developing inflammatory rheumatic diseases (psoriasis, anti-CCP-positive patients (preRA)), and patients with degenerative joint diseases (gonarthrosis) are being recruited for the study. - Age > 18 years - Written consent to participate in the study and data protection - Willingness and ability to participate in the study; sufficient knowledge of German to understand the consent form and questionnaires, or, if this is not possible, information for participants and support in their native language or, if necessary, in English. - High probability that patients will be able to participate in the full scope of the study. - A signed consent form is required for all patients to participate in this study (the information and consent form is included with the application).

Exclusion criteria

Exclusion criteria: - Pregnancy - No change in systemic immunosuppressive therapy in the last 3 months and during the intervention period (follow-up is excluded).

Design outcomes

Primary

MeasureTime frame
1. Can the quality of life (SF-36) of rheumatic patients be improved within 8 weeks using the PhysioFit app? 2. Can pain (PAIN, VRS) be reduced in patients with rheumatic diseases within 8 weeks using the PhysioFit app?

Secondary

MeasureTime frame
Does the use of the PhysioFit app lead to an improvement in health and exercise competence (PAHCO, EQ-5D-L) in patients with rheumatic diseases within 8 weeks? 2. How does the PhysioFit app influence exercise anxiety (TSK) in patients with rheumatic diseases within 8 weeks?

Countries

Germany

Contacts

Public ContactHarriet Morf

Uniklinik Erlangen

harriet.morf@uk-erlangen.de+4991318543023

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026